Seeking Alpha

Cubist Pharmaceuticals (CBST) reports Q4 revenue of $245.9M (+16% Y/Y) and FY12 revenue at...

Cubist Pharmaceuticals (CBST) reports Q4 revenue of $245.9M (+16% Y/Y) and FY12 revenue at $926.4M (+23% Y/Y). (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)